For years, Gilberto Chierice, a Chemistry Professor at the São Carlos campus of the University of São Paulo, used resources from a campus laboratory to unofficially manufacture, distribute, and promote the drug to cancer patients without it having gone through clinical testing. In September 2015, university administrators began preventing the Professor from continuing with this practice.
Gilberto Chierice, a Chemistry Professor at the University of São Paulo, used lab resources to secretly manufacture, distribute, and promote the drug to cancer patients without clinical testing. In September 2015, university officials stopped him from continuing.